Your session is about to expire
← Back to Search
Aerobic vs Resistance Exercise for Type 1 Diabetes
N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with type 1 diabetes for at least one year
Post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
Must not have
Use of medications (other than insulin) that affect glucose metabolism
History of cardiovascular disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 minutes to 45 minutes (during exercise)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the effects of different types of exercise on blood sugar levels in people with diabetes.
Who is the study for?
This trial is for post-menopausal women with Type 1 Diabetes who can exercise and visit the lab in Edmonton. They should have stable diabetes management, no severe complications like heart disease or neuropathy, not smoke, drink heavily, or be significantly overweight.
What is being tested?
The study compares how moderate aerobic exercise (like walking), resistance training (like weight-lifting), and no exercise affect blood sugar levels in these women. Blood samples will be taken during and after sessions to monitor glucose changes.
What are the potential side effects?
While there are generally no direct side effects from participating in moderate exercise, individuals may experience low blood sugar episodes or muscle soreness. It's important to follow safety guidelines provided by the researchers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 1 diabetes for over a year.
Select...
I have been in menopause for at least a year or have had my uterus and ovaries removed.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking medication that affects my blood sugar, not including insulin.
Select...
I have a history of heart disease.
Select...
I have severe nerve pain or numbness in my hands or feet.
Select...
I often have sudden low blood sugar levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Blood glucose
Secondary study objectives
carbohydrate supplementation
coefficient of variation (CV) of CGM glucose
frequency of hyperglycemia
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment3 Interventions
All participants will take part in all three testing conditions
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
942 Previous Clinical Trials
434,389 Total Patients Enrolled
Women and Children's Health Research Institute, CanadaOTHER
17 Previous Clinical Trials
24,880 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with type 1 diabetes for over a year.Your blood pressure is higher than 140 over 95.I have been in menopause for at least a year or have had my uterus and ovaries removed.I am taking medication that affects my blood sugar, not including insulin.I have a history of heart disease.I have severe nerve pain or numbness in my hands or feet.You have a body mass index (BMI) higher than 30.You are able to do cardio and strength exercises.I often have sudden low blood sugar levels.You are a smoker.You have injuries that make it hard for you to do physical activities.Your HbA1c level is higher than 9.9%.You drink more than two alcoholic drinks every day.I have not changed my insulin management in the last 2 months.
Research Study Groups:
This trial has the following groups:- Group 1: All participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.